ASCB/EMBO Neurodegenerative Mtg

[ASCBINFO]

                 Fourth Joint American Society for Cell Biology/
               European Molecular Biology Organization Conference

CYTOSKELETAL PROTEINS AND NEURODEGENERATIVE
DISEASE


                        ROBINSON COLLEGE, CAMBRIDGE, U.K.
                                August 5-10, 1995



Organizers: Lester Binder, Molecular Geriatrics Corporation, Lake Bluff, 
IL
            Michel Goedert, Medical Research Council, Cambridge, U.K.


      The fourth joint American Society for Cell Biology/European 
Molecular
Biology
Organization conference will examine the contributions of cytoskeletal
abnormalities to
neurodegenerative disease.  The format is designed to acquaint members of 
the
basic
science community with the involvement of specific proteins in disease
processes and to
afford clinical scientists the benefit of the latest cell and molecular
biological findings
regarding the proteins of interest.  The diseases covered will include
Alzheimer's
Disease, Amyotrophic Lateral Sclerosis, Stroke, Lewy Body Disease, Prion
Protein
Diseases, Multiple System Atrophy and Inclusion Body Myositis.  

      The biology and pathology of microtubule and intermediate filament
proteins in
normal and degenerating nervous systems will constitute major foci of
presentations
and discussions.  Invited presentations will be augmented by poster 
sessions
providing
more detailed coverage of individual topics.  Meeting attendance will be
limited to 250
participants.

      For a meeting application and call for abstracts contact Dorothy 
Doyle,
American Society for Cell Biology, 9650 Rockville Pike, Bethesda MD 
20814.
Tel: 301-530-7153; Fax: 301-530-7139; e-mail: ddoyle at ascb.faseb.org. 
Deadline for receipt of registration is April 28, 1995.  

                   CYTOSKELETAL PROTEINS AND NEURODEGENERATIVE DISEASE
                                    August 5-10, 1995
                                            
                                        SPEAKERS


Ueli Aebi
Maurice E. M
ller Institute
University of Basel 

Brian Anderton
Institute of Psychiatry
London 

David Armstrong
Allegheny-Singer 
Research Institute
Pittsburgh

Valerie Askanas
University of Southern
California
Los Angeles 

Jesus Avila
Universitad Autonoma de
Madrid

Heiko Braak
University of Frankfurt

Jean-Pierre Brion
Universit Libre de Bruxelles

Don Cleveland
Johns Hopkins University 
School of Medicine
Baltimore 

Philip Cohen
University of Dundee

Nicholas Cowan
New York University 
College of Medicine

Tony Crowther
Medical Research Council
Cambridge

Peter Davies
Albert Einstein 
College of Medicine  
New York

Craig Garner
University of Alabama
Birmingham





Bernardino Ghetti
Indiana University 
School of Medicine
Indianapolis 

Robert Goldman
Northwestern University 
Medical School
Chicago 

J
rgen Gtz
Institut f
r Molekularbiologie
Univeristy of Zurich

Nobutaka Hirokawa
University of Tokyo 
School of Medicine 

Khalid Iqbal
New York Institute 
for Basic Research
New York

Gail Johnson
University of Alabama
Birmingham 

Jean-Pierre Julien
Montreal General Hospital 
 
Ken Kosik
Harvard Medical School
Boston 

Virginia Lee
University of Pennsylvania 
School of Medicine
Philadelphia 

Ronald Liem
Columbia University 
College of Physicians and
Surgeons
New York 

Eva-Maria Mandelkow
Max Planck Gesellschaft
Hamburg 

Eckhard Mandelkow
Max Planck Gesellschaft
Hamburg 




Andrew Matus
Friedrich Miescher Institute
Basel

Ralph A. Nixon
McLean Hospital
Belmont 

Jacques Nunez
INSERM
Crteil 

Harish Pant
NIH/NINDS
Bethesda 

Elaine Perry
Medical Research Council
Newcastle upon Tyne

Donald Price
Johns Hopkins University 
School of Medicine
Baltimore 

Alphonse Probst
University of Basel

Allen Roses 
Duke University 
School of Medicine
Durham 

Maria Grazia Spillantini
Medical Research Council
Cambridge

John Trojanowski
University of Pennsylvania 
School of Medicine
Philadelphia 

Eugeen Vanmechelen
Innogenetics
Ghent

Shu-Hui Yen
Albert Einstein 
College of Medicine
New York